Factors influencing uptake of intermittent preventive treatment of malaria in pregnancy using sulphadoxine pyrimethamine in Sunyani Municipality, Ghana

• Published in: The Pan African medical journal 2017, Vol.28 (122), p.122-122
• Main Authors: Ibrahim, Hajira, Maya, Ernest Tei, Issah, Kofi, Apanga, Paschal Awingura, Bachan, Emmanuel George, Noora, Charles Lwanga
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Age; Anemia; Antimalarials - administration & dosage; Birth weight; Clinics; Confidence intervals; Cross-Sectional Studies; Drug Combinations; Education; Female; Ghana; Health Knowledge, Attitudes, Practice; Humans; Infections; Influence; intermittent preventive treatment; Malaria; Malaria - prevention & control; Marital status; Patient Acceptance of Health Care - statistics & numerical data; Population; Pregnancy; Pregnancy Complications, Parasitic - prevention & control; Prenatal Care - methods; Prevention; Pyrimethamine - administration & dosage; Sulfadoxine - administration & dosage; sulphadoxine pyrimethamine; uptake; Womens health; Young Adult
• ISSN: 1937-8688; 1937-8688
• DOI: 10.11604/pamj.2017.28.122.12611

Malaria continues to pose a public health challenge in Ghana particularly in pregnant women. Ghana adopted intermittent preventive treatment of malaria in pregnancy policy using sulphadoxine pyrimethamine. Despite its implementation, its coverage still remains low. This study sought to investigate factors that influence the uptake of intermittent preventive treatment of malaria in pregnancy in the Sunyani Municipality. This was a cross sectional study which employed a quantitative method. The study was conducted in five selected facilities in the Sunyani Municipality within the period of January to June 2015. Structured questionnaires were administered to 400 pregnant women randomly sampled from antenatal clinics of selected health facilities. Descriptive, bivariate and multivariate analysis of quantitative data was done using Stata12. A total of 400 pregnant women at 36 weeks or more gestational age were studied. The study revealed that 98.5% of the pregnant women received at least one (1) dose of sulphadoxine pyrimethamine during the current pregnancy with 71% receiving optimal (at least 3 doses) doses of sulphadoxine pyrimethamine for intermittent preventive treatment of malaria in pregnancy at the time of study. The study revealed that women who attended ANC ≥4 times (Adjusted OR = 4.7, 95% CI 1.31-17.2), knowledge of malaria in pregnancy (Adjusted OR = 2.2, 95% CI 1.03-4.62) and knowledge of intermittent preventive treatment for malaria in pregnancy (Adjusted OR = 1.8, 95% CI 1.15-2.96) were found to be positively associated with the uptake of optimal doses of sulphadoxine pyrimethamine. This study has demonstrated that having a good knowledge of malaria in pregnancy and intermittent preventive treatment of malaria in pregnancy can significantly influence the uptake of optimal doses of sulphadoxine pyrimethamine. Encouraging women to attend antenatal care regularly (at least four visits) could also increase the optimal uptake of sulphadoxine pyrimethamine.